Andere talen Bone Biologics Corporation

Aandelen

BBLG

US0980705018

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,5 ^USD	-0,66%		-17,58%	-66,81%

01/03	Bone Biologics Corporation rapporteert vooruitgang met NB1 klinisch programma	CI
21/02	Bone Biologics Corporation rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Certain Common Stock of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	04/05
Certain Warrants of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	04/05
Certain Stock Options of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	04/05
Bone Biologics Announces Closing of $2.0 Million Public Offering	06/03
Bone Biologics Announces Pricing of $2.0 Million Public Offering	04/03
Bone Biologics Corporation Reports Progress with NB1 Clinical Program	01/03
Bone Biologics Reports Progress With NB1 Clinical Program	01/03
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	21/02
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors	11/01
Bone Biologics Corporation Announces Board Changes	11/01
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements	10/01
Bone Biologics Corporation Announces the Resignation of Erick Lucera as Director	02/01
Bone Biologics' 1-for-8 Reverse Stock Split Takes Effect Wednesday	18/12
Bone Biologics Announces 1-for-8 Reverse Stock Split	18/12
Bone Biologics Closes Common Stock Offering; Shares Fall After Hours	20/11
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	20/11
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	16/11
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Nano-Cap Medical Technology Watchlist (ORHB, BBLG, ICU, RMTI)	02-10-23
Bone Biologics Provides Scientific Update on NB1 Bone Graft Device	26-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bone Biologics Corporation

Aandelen

BBLG

US0980705018

Andere talen

Filters